CLL patients with high PTEN expression had significantly shorter TTT than those with low expression of PTEN (median 0.74 years vs. 4.3 years for (p < 0.0001), Figure S5c). This evidence concerns the gene PTEN and B-cell chronic lymphocytic leukemia.